Developer docs
API playgroundTry for free, no card

Search company profiles

CART-Tech

Full company profile

uuid000jwxr

Namestring
CART-Tech
Websiteurl
cart-tech.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

CART-Tech is a privately held medical technology company headquartered in Utrecht, the Netherlands, founded in 2014. According to its firmographic profile, the company develops an image-guided technology device for cardiac resynchronization therapy (CRT), a treatment used in patients with heart failure to synchronize ventricular contractions via an implantable device. The implied clinical value proposition is to improve the precision of CRT lead placement or patient selection through image guidance, which is a recognized challenge in the field. The company is led by co-founder and Chief Executive Officer Paul Leufkens.

The organization operates at very small scale, with a headcount reported as 1-10 employees, consistent with an early-stage medical device venture. No products have been publicly catalogued, no pricing or revenue model has been disclosed, and the company website (cart-tech.com) currently presents only a loading/verification page with no substantive product, regulatory, or operational information. There are no recorded funding rounds, acquisitions, partnerships, certifications, patents, or named customers in the available source data, indicating that CART-Tech has not yet achieved visible commercial or regulatory milestones in public records.

Given the absence of disclosed commercialization signals, the company most likely remains in a research, prototyping, or pre-clinical/pre-commercial stage of development. The narrow technical focus on image-guided CRT positions CART-Tech in the cardiology medtech subsegment, addressing a real procedural challenge but competing in a space dominated by large incumbents (Medtronic, Abbott, Boston Scientific, Biotronik). Investors evaluating CART-Tech should treat the available data set as severely information-constrained and weight diligence toward regulatory pathway, IP estate, clinical evidence, and management track record accordingly.

Short descriptiontext

CART-Tech is a Utrecht-based medical technology company founded in 2014 that develops an image-guided technology device for cardiac resynchronization therapy. The privately held firm, led by CEO and co-founder Paul Leufkens, operates with fewer than 10 employees.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersUtrecht, Netherlands
HQ citystring
Utrecht
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
cardiac resynchronization therapy, image-guided medical devices, heart failure treatment, cardiac intervention technology, electrophysiology devices
Industry1 code
PRIMARYHLAHAFAC
Cardiac Rhythm Management (Pacemakers, ICDs, CRT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Cardiac Resynchronization Therapy Devices
Social media profiles1 record
Cost components4 values
Personnel, Technology or R&D, Operations, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

CART-Tech develops an image-guided technology device used during cardiac resynchronization therapy (CRT), a treatment for patients with heart failure. The device supports clinicians by providing image-guided navigation to improve the placement and delivery of CRT therapy.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Image-guided CRT device
Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Peers10 records
TypeBroad incumbent
Description

Global leader in cardiac rhythm management with extensive CRT-D and CRT-P product lines and deep clinical relationships. Comparable as the dominant incumbent CART-Tech would need to displace or partner with.

2Abbott
TypeBroad incumbent
Description

Major CRT device manufacturer (Gallant, Quadra Assura families) with full electrophysiology portfolio. Comparable as an incumbent competitor and potential strategic acquirer in the same clinical procedure.

TypeBroad incumbent
Description

Sells CRT-D systems and is investing in next-generation pacing including conduction system pacing. Comparable as a leading CRT incumbent competing for the same hospital accounts.

TypeDirect peer
Description

Germany-based specialist in cardiac rhythm management with a focused CRT product line. Most directly comparable in scale and CRT-only focus, making it the closest head-to-head competitor.

TypeEmerging player
Description

Developer of the WiSE wireless cardiac stimulation system for CRT, an alternative-leadless approach. Comparable as a small, venture-stage company pursuing novel CRT technology that competes for clinical mindshare.

TypeDirect peer
Description

Cardiac rhythm management division of MicroPort focused on pacemakers and CRT-D devices. Comparable as a focused CRT manufacturer serving similar cardiology customers.

TypeEmerging player
Description

Italy-based developer of adaptive neuromodulation technology with potential cardiac applications. Comparable as a small European medical-device innovator pursuing sensing/closed-loop approaches in cardiac care.

TypeBroad incumbent
Description

Medical device company with a cardiac surgery and neuromodulation portfolio including cardiac support technologies. Comparable as an established cardiac-focused device manufacturer addressing similar patient populations.

TypeEmerging player
Description

Developer of novel pacing-based therapies for hypertension and heart failure, overlapping CRT clinical indications. Comparable as a venture-stage company pursuing device-based heart-failure therapy innovation.

TypeEmerging player
Description

Cardiac diagnostic company applying signal processing and machine learning to heart failure and structural heart disease. Comparable as a small company applying novel technology to the cardiac care continuum that CRT also addresses.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CART-Tech

Cardiac Resynchronization Therapy Devicescart-tech.com

CART-Tech is a Utrecht-based medical technology company founded in 2014 that develops an image-guided technology device for cardiac resynchronization therapy. The privately held firm, led by CEO and co-founder Paul Leufkens, operates with fewer than 10 employees.

What CART-Tech does

CART-Tech is a privately held medical technology company headquartered in Utrecht, the Netherlands, founded in 2014. According to its firmographic profile, the company develops an image-guided technology device for cardiac resynchronization therapy (CRT), a treatment used in patients with heart failure to synchronize ventricular contractions via an implantable device. The implied clinical value proposition is to improve the precision of CRT lead placement or patient selection through image guidance, which is a recognized challenge in the field. The company is led by co-founder and Chief Executive Officer Paul Leufkens.

The organization operates at very small scale, with a headcount reported as 1-10 employees, consistent with an early-stage medical device venture. No products have been publicly catalogued, no pricing or revenue model has been disclosed, and the company website (cart-tech.com) currently presents only a loading/verification page with no substantive product, regulatory, or operational information. There are no recorded funding rounds, acquisitions, partnerships, certifications, patents, or named customers in the available source data, indicating that CART-Tech has not yet achieved visible commercial or regulatory milestones in public records.

Given the absence of disclosed commercialization signals, the company most likely remains in a research, prototyping, or pre-clinical/pre-commercial stage of development. The narrow technical focus on image-guided CRT positions CART-Tech in the cardiology medtech subsegment, addressing a real procedural challenge but competing in a space dominated by large incumbents (Medtronic, Abbott, Boston Scientific, Biotronik). Investors evaluating CART-Tech should treat the available data set as severely information-constrained and weight diligence toward regulatory pathway, IP estate, clinical evidence, and management track record accordingly.

CART-Tech firmographics

Firmographics
Name
CART-Tech
Website
https://cart-tech.com
Company type
Private
Founded year
2018
Headcount range
1–10 employees
Short description
CART-Tech is a Utrecht-based medical technology company founded in 2014 that develops an image-guided technology device for cardiac resynchronization therapy. The privately held firm, led by CEO and co-founder Paul Leufkens, operates with fewer than 10 employees.
Ownership category
akta.pro rank

CART-Tech industry classification

Industry
Product category
Cardiac Resynchronization Therapy Devices
NAICS
Scientific Research and Development Services (5417)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHLAHAFAC
Cardiac Rhythm Management (Pacemakers, ICDs, CRT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)

Keywords

  • Cardiac resynchronization therapy
  • Image-guided medical devices
  • Heart failure treatment
  • Cardiac intervention technology
  • Electrophysiology devices

Where CART-Tech is headquartered

Location

Headquarters

HQ city
Utrecht
HQ country
Netherlands
HQ region
Europe

Markets served

CART-Tech business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain

CART-Tech product offering

Product offering

Core offering

CART-Tech develops an image-guided technology device used during cardiac resynchronization therapy (CRT), a treatment for patients with heart failure. The device supports clinicians by providing image-guided navigation to improve the placement and delivery of CRT therapy.

Differentiator

Problem solved

Functional benefit

Products and services

  • Image-guided CRT device

Companies that use CART-Tech

Customer profile

Ideal customer profiles1 record

CART-Tech technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

CART-Tech partnerships and signals

Strategic signal

Recent moves2 records

CART-Tech competitors and assessment

Company assessment

Broad incumbents

  • Medtronic: Global leader in cardiac rhythm management with extensive CRT-D and CRT-P product lines and deep clinical relationships. Comparable as the dominant incumbent CART-Tech would need to displace or partner with.
  • Abbott: Major CRT device manufacturer (Gallant, Quadra Assura families) with full electrophysiology portfolio. Comparable as an incumbent competitor and potential strategic acquirer in the same clinical procedure.
  • Boston Scientific: Sells CRT-D systems and is investing in next-generation pacing including conduction system pacing. Comparable as a leading CRT incumbent competing for the same hospital accounts.
  • LivaNova: Medical device company with a cardiac surgery and neuromodulation portfolio including cardiac support technologies. Comparable as an established cardiac-focused device manufacturer addressing similar patient populations.

Direct peers

  • Biotronik: Germany-based specialist in cardiac rhythm management with a focused CRT product line. Most directly comparable in scale and CRT-only focus, making it the closest head-to-head competitor.
  • MicroPort CRM: Cardiac rhythm management division of MicroPort focused on pacemakers and CRT-D devices. Comparable as a focused CRT manufacturer serving similar cardiology customers.

Emerging players

  • EBR Systems: Developer of the WiSE wireless cardiac stimulation system for CRT, an alternative-leadless approach. Comparable as a small, venture-stage company pursuing novel CRT technology that competes for clinical mindshare.
  • Newronika: Italy-based developer of adaptive neuromodulation technology with potential cardiac applications. Comparable as a small European medical-device innovator pursuing sensing/closed-loop approaches in cardiac care.
  • BackBeat Medical: Developer of novel pacing-based therapies for hypertension and heart failure, overlapping CRT clinical indications. Comparable as a venture-stage company pursuing device-based heart-failure therapy innovation.
  • CorVista Health: Cardiac diagnostic company applying signal processing and machine learning to heart failure and structural heart disease. Comparable as a small company applying novel technology to the cardiac care continuum that CRT also addresses.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

CART-Tech social profiles

Digital presence

CART-Tech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CART-Tech leadership team

Management profile

Number of profiles

Profiles1 record

CART-Tech funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CART-Tech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CART-Tech

What does CART-Tech do?

CART-Tech develops an image-guided technology device used during cardiac resynchronization therapy (CRT), a treatment for patients with heart failure. The device supports clinicians by providing image-guided navigation to improve the placement and delivery of CRT therapy.

When was CART-Tech founded?

CART-Tech was founded in 2018. It employs 1 to 10 people.

Where is CART-Tech based?

CART-Tech is headquartered in Utrecht, Netherlands, in the Europe region.

Who are CART-Tech's main competitors?

Broad incumbents on record are Medtronic, Abbott, Boston Scientific and LivaNova. Direct peers are Biotronik and MicroPort CRM. Emerging players are EBR Systems, Newronika, BackBeat Medical and CorVista Health.

Does CART-Tech have an API?

No public API is recorded for CART-Tech.

What industry is CART-Tech in?

CART-Tech's product category is Cardiac Resynchronization Therapy Devices. Its primary akta.pro industry code is HLAHAFAC, Cardiac Rhythm Management (Pacemakers, ICDs, CRT). Its NAICS code is 5417 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals